Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HKI-357 dimaleate is an irreversible dual inhibitor of EGFR and ERBB2. HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | HKI-357 dimaleate is an irreversible dual inhibitor of EGFR and ERBB2. HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation. |
Molecular Weight | 806.2 |
Formula | C39H37ClFN5O11 |
CAS No. | 915942-25-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HKI-357 dimaleate 915942-25-5 HKI-357 Dimaleate HKI 357 dimaleate HKI357 Dimaleate HKI357 dimaleate HKI 357 HKI-357 HKI 357 Dimaleate HKI357 inhibitor inhibit